The U.S. Food and Drug Administration (FDA) have issued a warning to consumers and medical professionals. FDA labs have verified that a counterfeit version of Roche’s Altuzan 400mg/16ml (bevacizumab) has been found in the U.S. Altuzan is used to treat a certain type of brain tumor as
Read more →
A nationwide recall of of seven (7) lots (8 million pills) of oral contraceptives Norgestimate and Ethinyl Estradiol Tablets USP (0.18 mg/0.035 mg, 0.215 mg/0.035 mg, 0.25 mg/0.035 mg) has been issued by Glenmark Generics Inc. The recall was issued as a result of a packaging error
Read more →
The U.S. Food and Drug Administration (FDA) has issued a warning to Oncology physicians, pharmacies and patients about a counterfeit version of Avastin 400mg/16mL. The counterfeit Avastin may have been bought and administered by some U.S. medical practices. The counterfeit version is labeled and the Roche version
Read more →Pfizer Inc. has notified medical professionals and consumers that it has recalled 14 lots of Lo/Ovral-28 Tablets and 14 lots of the generic equivalent, Norgestrel and Ethinyl Estradiol Tablets, for consumers in the U.S. market. A Pfizer investigation revealed the oral contraceptive tablets found that the blister
Read more →The European Medicines Agency (EMA) will allow Actos, to remain on the market in Europe, with more serious warnings regarding potential bladder cancer risks. Actos is Takeda Pharmaceutical’s controversial Type 2 diabetes drug. A report from the EMA’s Committee for Medicinal Products for Human Use determined that
Read more →The Food & Drug Administration (FDA) is showing an increasing willingness to bring criminal charges against drug company executives in a quest to the corporate culture of an industry that seems to be immune to billion-dollar fines. According to the Philadelphia Inquirer, the FDA has let it
Read more →In personal injury law, one area of interest and great concern is the off-label use of prescription drugs. Off-label drug use is defined as medications prescribed by a physician for use in a manner that is not consistent with the tested and approved use of the product.
Read more →In an article published yesterday, we wrote that GlaxoSmithKline agreed to pay $3 billion in order to settle several federal investigations into its drug marketing practices, including Avandia its Type 2 diabetes drug that has been linked to cardiovascular injuries. According to Bloomberg Businessweek, a U.S. District
Read more →Bloomberg News has reported that GlaxoSmithKline has agreed to pay $3 billion to resolve federal investigations into the marketing of some of its drugs, including Type 2 diabetes drug Avandia. The deal with the U.S. Justice Department would account for GlaxoSmithKline’s largest legal settlement to date. The
Read more →Two Illinois plaintiffs have filed a lawsuit against GlaxoSmithKline alleging they should have never sold Avandia without warning consumers about the potential for serious side effects, such as heart attacks and congestive heart failure which the plaintiffs state they have suffered. The lawsuit was filed by the
Read more →
Recent Comments